Is It Worth It?

(New/bonus content starts at 19:11. First part of episode originally aired June 7, 2022.)

Medicare is slowly moving forward on risk, but commercial risk is more of a wild card and the health care industry has yet to land on a clear model for the population. In this episode, Rachel Woods sits down with Advisory Board's Clare Wirth and Alex Tallian to discuss their research into commercial risk and why they believe commercial risk is possible for the health care industry.

Bonus links:

• Value-based care should be more than a buzzword by now
• 2 strategies used by independent groups to succeed in commercial risk
• The next chapter of population health involves specialists. Here’s where to start. (Part 1 of 3)

Links:

• The data on commercial risk opportunities (and where the research goes next)
• Are the barriers to commercial risk insurmountable? Here’s why they might be.
• Are the barriers to commercial risk insurmountable? No, they are not.
• Our Value-Based Care playlist